Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia. Issue 7 (7th June 2021) - Fodil, S.; Raffoux, E.; Dumas, P. Y.; Desbrosses, Y.; Larosa, F.; Chantepie, S.; Larcher, M. V.; Mear, J. B.; Peterlin, P.; Hunault-Berger, M.; Hospital, M. A.; Morel, V.; et al.